Amyloid β Levels in Human Red Blood Cells
Open Access
- 15 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11), e49620
- https://doi.org/10.1371/journal.pone.0049620
Abstract
Amyloid β-peptide (Aβ) is hypothesized to play a key role by oxidatively impairing the capacity of red blood cells (RBCs) to deliver oxygen to the brain. These processes are implicated in the pathogenesis of Alzheimer's disease (AD). Although plasma Aβ has been investigated thoroughly, the presence and distribution of Aβ in human RBCs are still unclear. In this study, we quantitated Aβ40 and Aβ42 in human RBCs with ELISA assays, and provided evidence that significant amounts of Aβ could be detected in RBCs and that the RBC Aβ levels increased with aging. The RBC Aβ levels increased with aging. On the other hand, providing an antioxidant supplement (astaxanthin, a polar carotenoid) to humans was found to decrease RBC Aβ as well as oxidative stress marker levels. These results suggest that plasma Aβ40 and Aβ42 bind to RBCs (possibly with aging), implying a pathogenic role of RBC Aβ. Moreover, the data indicate that RBC Aβ40 and Aβ42 may constitute biomarkers of AD. As a preventive strategy, therapeutic application of astaxanthin as an Aβ-lowering agent in RBCs could be considered as a possible anti-dementia agent. Controlled-Trials.com ISRCTN42483402Keywords
This publication has 38 references indexed in Scilit:
- Cerebrospinal Fluid Aβ and Tau Level Fluctuation in an Older Clinical CohortArchives of Neurology, 2012
- Amyloid β-induced erythrocytic damage and its attenuation by carotenoidsFEBS Letters, 2011
- Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytesBritish Journal of Nutrition, 2011
- Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-AmyloidosisScience, 2010
- Systemic Catabolism of Alzheimer's Aβ40 and Aβ42Online Journal of Public Health Informatics, 2004
- Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in PlasmaBiochemical and Biophysical Research Communications, 2000
- Aβ25–35 induces rapid lysis of red blood cells: contrast with Aβ1–42 and examination of underlying mechanismsBrain Research, 1997
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral ArteriesJournal of Neurochemistry, 1996
- Platelets Are the Primary Source of Amyloid β-Peptide in Human BloodBiochemical and Biophysical Research Communications, 1995